Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Predisposition to Disease | 14 | 2025 | 3175 | 1.940 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2025 | 505 | 1.840 |
Why?
|
| Biological Specimen Banks | 6 | 2025 | 51 | 1.570 |
Why?
|
| Genome, Human | 6 | 2025 | 1295 | 1.440 |
Why?
|
| Genetic Variation | 6 | 2025 | 1506 | 1.240 |
Why?
|
| Genome-Wide Association Study | 9 | 2025 | 1694 | 1.090 |
Why?
|
| Haploinsufficiency | 2 | 2025 | 258 | 1.040 |
Why?
|
| Genomics | 7 | 2025 | 1524 | 1.010 |
Why?
|
| Genes, Recessive | 1 | 2025 | 185 | 0.890 |
Why?
|
| Proteomics | 3 | 2025 | 509 | 0.890 |
Why?
|
| Blood Proteins | 1 | 2023 | 124 | 0.830 |
Why?
|
| Biological Evolution | 2 | 2022 | 227 | 0.790 |
Why?
|
| Epilepsy | 2 | 2023 | 874 | 0.770 |
Why?
|
| Synapses | 1 | 2025 | 452 | 0.740 |
Why?
|
| Transcriptome | 3 | 2024 | 980 | 0.730 |
Why?
|
| Selection, Genetic | 3 | 2022 | 154 | 0.720 |
Why?
|
| Mutation, Missense | 3 | 2025 | 878 | 0.720 |
Why?
|
| Genetic Association Studies | 2 | 2023 | 781 | 0.680 |
Why?
|
| Neurons | 5 | 2024 | 1942 | 0.670 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 427 | 0.660 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 114 | 0.650 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 135 | 0.640 |
Why?
|
| Parkinson Disease | 1 | 2025 | 690 | 0.570 |
Why?
|
| Schizophrenia | 2 | 2021 | 312 | 0.560 |
Why?
|
| Genetic Testing | 1 | 2024 | 1014 | 0.550 |
Why?
|
| Machine Learning | 3 | 2025 | 251 | 0.540 |
Why?
|
| Exome | 4 | 2025 | 1036 | 0.530 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 664 | 0.530 |
Why?
|
| United Kingdom | 7 | 2025 | 190 | 0.520 |
Why?
|
| Complement C4 | 1 | 2016 | 5 | 0.510 |
Why?
|
| Databases, Genetic | 3 | 2025 | 478 | 0.400 |
Why?
|
| Case-Control Studies | 6 | 2025 | 3313 | 0.380 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2528 | 0.380 |
Why?
|
| Germ-Line Mutation | 2 | 2025 | 342 | 0.370 |
Why?
|
| Humans | 30 | 2025 | 125757 | 0.360 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 289 | 0.330 |
Why?
|
| Mutation | 6 | 2023 | 5909 | 0.300 |
Why?
|
| Animals | 10 | 2025 | 34392 | 0.260 |
Why?
|
| Biomarkers | 3 | 2024 | 3098 | 0.260 |
Why?
|
| Software | 2 | 2022 | 687 | 0.250 |
Why?
|
| Anticonvulsants | 2 | 2020 | 384 | 0.240 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 283 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 396 | 0.230 |
Why?
|
| Rhombencephalon | 1 | 2024 | 49 | 0.220 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 122 | 0.220 |
Why?
|
| PubMed | 1 | 2023 | 20 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2025 | 2653 | 0.210 |
Why?
|
| Plasma | 1 | 2023 | 99 | 0.210 |
Why?
|
| Telomere | 1 | 2024 | 220 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 45 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2024 | 357 | 0.200 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2022 | 8 | 0.200 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2022 | 9 | 0.200 |
Why?
|
| Autism Spectrum Disorder | 2 | 2025 | 393 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2023 | 1186 | 0.190 |
Why?
|
| Hematopoiesis | 1 | 2023 | 217 | 0.190 |
Why?
|
| Phenotype | 5 | 2024 | 4274 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 64 | 0.180 |
Why?
|
| Homozygote | 1 | 2023 | 547 | 0.180 |
Why?
|
| Epirizole | 1 | 2020 | 2 | 0.180 |
Why?
|
| Trimipramine | 1 | 2020 | 2 | 0.180 |
Why?
|
| Perphenazine | 1 | 2020 | 6 | 0.180 |
Why?
|
| Trazodone | 1 | 2020 | 6 | 0.180 |
Why?
|
| Aged | 6 | 2025 | 19899 | 0.180 |
Why?
|
| Carbamazepine | 1 | 2020 | 48 | 0.180 |
Why?
|
| Heterozygote | 1 | 2023 | 672 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 48 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.170 |
Why?
|
| Codon | 1 | 2020 | 98 | 0.170 |
Why?
|
| Drosophila | 1 | 2025 | 777 | 0.170 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 222 | 0.170 |
Why?
|
| Risperidone | 1 | 2020 | 59 | 0.170 |
Why?
|
| Disease | 1 | 2021 | 129 | 0.170 |
Why?
|
| Computational Biology | 3 | 2024 | 820 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 109 | 0.160 |
Why?
|
| RNA Stability | 1 | 2020 | 84 | 0.160 |
Why?
|
| Drosophila melanogaster | 1 | 2025 | 773 | 0.160 |
Why?
|
| Cerebellum | 1 | 2023 | 439 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2020 | 171 | 0.160 |
Why?
|
| Drosophila Proteins | 1 | 2025 | 716 | 0.160 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 286 | 0.160 |
Why?
|
| Genotype | 2 | 2023 | 2569 | 0.150 |
Why?
|
| RNA Splicing | 1 | 2020 | 228 | 0.150 |
Why?
|
| Alleles | 1 | 2023 | 1617 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 195 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 307 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 2715 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 296 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2020 | 654 | 0.140 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 374 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 669 | 0.130 |
Why?
|
| Mice | 6 | 2024 | 17758 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1549 | 0.130 |
Why?
|
| Action Potentials | 1 | 2018 | 502 | 0.120 |
Why?
|
| Male | 8 | 2025 | 61813 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 168 | 0.120 |
Why?
|
| Risk Factors | 2 | 2025 | 10341 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1762 | 0.110 |
Why?
|
| Female | 7 | 2025 | 67035 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1271 | 0.100 |
Why?
|
| Algorithms | 3 | 2024 | 1634 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 443 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 887 | 0.080 |
Why?
|
| Genetics, Population | 2 | 2022 | 188 | 0.080 |
Why?
|
| Middle Aged | 5 | 2025 | 27003 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1916 | 0.060 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2025 | 36 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2025 | 45 | 0.060 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2025 | 97 | 0.060 |
Why?
|
| Mexico | 1 | 2025 | 182 | 0.060 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 44 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 24 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 139 | 0.050 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 140 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2025 | 6173 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2024 | 237 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 31 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 198 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 24 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 58 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2022 | 91 | 0.050 |
Why?
|
| Cell Division | 1 | 2023 | 784 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 189 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 85 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2021 | 17 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 196 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 148 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 172 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 860 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2023 | 625 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 150 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 576 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 760 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 1011 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 523 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2018 | 42 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 872 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1641 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2018 | 271 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2017 | 211 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 714 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 1038 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 1763 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 761 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2918 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3063 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 2252 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3755 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 29760 | 0.010 |
Why?
|